IADR Abstract Archives

In vitro antimicrobial efficacy of an oral rinse

A commercially-available non-alcohol oral rinse (Crest Pro-Health Rinse, Procter&Gamble) has been marketed for use in reducing oral plaque and gingivitis. Objective: Compare the in-vitro effectiveness of two commercially-available oral rinses, one containing cetylpyridinium chloride (Crest Pro-Health Rinse) and the other containing cetylpyridinium chloride and alcohol (Cepacol, Combe), in reducing viability of common oral flora. Methods: Five species of oral flora (S.sanguinus, S.mutans, L.casei, A.odontolyticus, and C.albicans) were grown in culture, suspended in normal saline on 96-well plates, and exposed to each of three oral-antimicrobial rinses – Peridex (Zila), Cepacol, Crest Pro-Health Rinse - or a control group (no antimicrobial rinse) (n=24). Species were exposed to a fluorescent dye, alamar blue (Biocourse), which is reduced by bacteria causing fluorescence. Viability was demonstrated through fluorescence readings on a spectrophotometer (Synergy, BioTek) at 485/590nm. Species were cultured and cfu/mL were determined after each treatment in order to compare with fluorescence readings (n=3). Mean fluorescence, cfu/mL and st dev were determined and comparisons were made using 1-way ANOVA/Tukey HSD (alpha=0.05). Results: Different results were observed between fluorescence and cfu techniques for A.odontolyticus and C.albicans, however, exposure to all three oral rinses significantly reduced fluorescence readings for the remaining species vs. control (p<.001). No significant differences in cfu/mL or fluorescence were found between Cepacol and Crest Pro Health Rinse (p>.05). For three bacteria, Cepacol and Crest Pro Health Rinse performed significantly better (cfu/mL) than Peridex and control (p<.01). Conclusions: Alamar blue fluorescence may not be accurate test for determining viability of all oral species. All three rinses significantly reduced the number of bacteria (cfu/mL) vs. control. Removing alcohol from the oral rinse did not significantly affect its efficacy in-vitro. Tables: different letters denote significant differences by column.  

cfu/mL – mean (st dev)

 

Rinse

Bacteria

S.sanguinus

S.mutans

L.casei

A.odontolyticus

C.albicans

Cepacol

3.97x104 (3.61x104) a

2.57 x104 (1.79 x104) a

9.47 x104 (1.35 x105) a

3.49 x106 (2.55 x106) a

1.63 x106 (8.39 x107) a

Crest PHR

4.33 x101 (3.51 x101) a

6.00 x104 (0.00 x100) a

2.00 x101 (1.00 x101) a

1.83 x102 (6.43 x101) a

1.20 x105 (9.64 x104) a

Peridex

3.36 x107 (2.4 x107) a

5.67 x107 (5.51 x106) b

2.90 x107 (5.00 x106) b

3.70 x108 (6.08 x107) b

6.13 x104 (5.86 x103) a

No tx

1.02 x108 (1.69 x107) b

5.67 x107 (1.59 x107) c

2.67 x107 (8.39 x106) c

5.30 x108 (4.00 x107) c

1.03 x107 (1.53 x106) b

 

fluorescence – mean (st dev)

 

Rinse

Bacteria

S.sanguinus

S.mutans

L.casei

A.odontolyticus

C.albicans

Cepacol

124.33 (1.94) a

121.29 (0.71) a

122.79 (6.84) a

239.50 (50.65) a

143.95 (0.87) a

Crest PHR

118.62 (1.44) a

118.96 (3.38) a

122.79 (3.63) a

138.12 (5.44) a

135.57 (2.20) a

Peridex

169.08 (1.75) b

172.17 (5.48) b

161.79 (1.70) b

4395.09 (123.79) c

606.67 (14.36) c

No tx

232.83 (5.15) c

227.00 (3.81) c

257.25 (8.37) c

2281.67 (63.17) b

180.19 (0.93) b

 

 


Division: IADR/AADR/CADR General Session
Meeting: 2007 IADR/AADR/CADR General Session (New Orleans, Louisiana)
Location: New Orleans, Louisiana
Year: 2007
Final Presentation ID: 1131
Abstract Category|Abstract Category(s): Microbiology / Immunology and Infection Control
Authors
  • Klingman, David  ( USAF, Lackland AFB, TX, USA )
  • Chong, Chol H.  ( USAF, Lackland AFB, TX, USA )
  • Hensley, Donna M.  ( USAF, Lackland AFB, TX, USA )
  • SESSION INFORMATION
    Poster Session
    Clinical Microbiology of the Oral Cavity I
    03/22/2007